Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) blacklists Onifam Laboratories Limited and its directors over alleged regulatory violations. Multiple outlets report that the sanction takes immediate effect and bars the company and the named individuals from all pharmaceutical business in Nigeria. NAFDAC says its action follows investigation and is linked to breaches of its regulatory requirements.
According to reports, NAFDAC also cites findings that the company may have circumvented regulatory controls involving regulated products. The agency’s description includes alleged conduct across the pharmaceutical value chain, including importation, distribution, marketing, or sponsorship of regulated products in ways that do not follow approved NAFDAC regulatory processes.
The blacklisting reportedly covers Onifam Laboratories, its managing director/chief executive officer, board members, and affiliated individuals and entities associated with the company. The outlets do not indicate the specific products involved or provide detailed evidence in the excerpts, but they consistently describe NAFDAC’s decision as a regulatory enforcement measure based on the alleged violations and circumvention of controls.
